You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TRAILBLAZER-ALZ

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mild Cognitive Impairment, Alzheimer Trial in United States (Donanemab, Aducanumab)

Active, not recruiting
  • Mild Cognitive Impairment
  • Alzheimer Disease
  • Fullerton, California
  • +30 more
Jan 18, 2023

Alzheimer's Disease, Dementia, Brain Diseases Trial in Italy, United Kingdom, United States (Donanemab, Placebo)

Not yet recruiting
  • Alzheimer's Disease
  • +7 more
  • Chandler, Arizona
  • +51 more
Feb 13, 2023

Alzheimer Trial in Canada, United States (Donanemab, Placebo, LY3202626)

Completed
Has Results
  • Alzheimer Disease
  • Phoenix, Arizona
  • +60 more
Sep 19, 2022

Alzheimer, Dementia, Brain Diseases Trial in Worldwide (Donanemab, Placebo)

Not yet recruiting
  • Alzheimer Disease
  • +8 more
  • Brussels, Bruxelles-Capitale, Région De, Belgium
  • +147 more
Aug 18, 2022

Alzheimer Trial in Worldwide (Donanemab, Placebo)

Active, not recruiting
  • Alzheimer Disease
  • Hoover, Alabama
  • +282 more
Apr 6, 2022

Alzheimer Trial in Japan, Puerto Rico, United States (Donanemab, Placebo)

Recruiting
  • Alzheimer Disease
  • Birmingham, Alabama
  • +215 more
Aug 9, 2022

Alzheimer Trial in East Providence, Austin (Simufilam)

Enrolling by invitation
  • Alzheimer Disease
  • East Providence, Rhode Island
  • +1 more
Jan 5, 2023

Early Alzheimer's Disease Trial in Worldwide (Experimental: ALZ-801, Placebo Comparator: Placebo)

Recruiting
  • Early Alzheimer's Disease
  • Experimental: ALZ-801
  • Placebo Comparator: Placebo
  • Phoenix, Arizona
  • +95 more
Aug 18, 2022

Alzheimer, Insomnia Disorder, Sleep Trial in Montpellier (drug, procedure, behavioral, other)

Not yet recruiting
  • Alzheimer Disease
  • +2 more
  • Daridorexant 50 mg
  • +7 more
  • Montpellier, France
    University Hospital, Montpellier
Jun 20, 2023

Alzheimer Trial in Turku (ALZ-101, Placebo)

Recruiting
  • Alzheimer Disease
  • ALZ-101
  • Placebo
  • Turku, Finland
    Clinical Research Services Turku -CRST Oy
Jun 9, 2022

Early Alzheimer's Disease Trial in Czechia, Netherlands (ALZ-801)

Active, not recruiting
  • Early Alzheimer's Disease
  • Brno, Czechia
  • +5 more
Aug 10, 2021

Alzheimer's Disease Trial in United States (Remternetug (IV), Remternetug (SC), Placebo)

Recruiting
  • Alzheimer's Disease
  • Remternetug (IV)
  • +2 more
  • Chandler, Arizona
  • +70 more
Aug 10, 2022

Alzheimer, Dementia, Brain Diseases Trial in Canada, United States (No Intervention, donanemab)

Active, not recruiting
  • Alzheimer Disease
  • +4 more
  • Phoenix, Arizona
  • +27 more
May 25, 2022

Alzheimer Trial (ALZ-801 170 mg Fasting, ALZ-801 205 mg Fasting, ALZ-801 205 mg After Food)

Completed
  • Alzheimer Disease
  • ALZ-801 170 mg Fasting
  • +3 more
  • (no location specified)
Oct 12, 2020

Alzheimer Trial in Ruddington (ALZ-801 or matching )

Completed
  • Alzheimer Disease
  • ALZ-801 or matching placebo
  • Ruddington, Nottingham, United Kingdom
    Quotient Clinical
Nov 15, 2019

Alzheimer Trial in Westport (roflumilast, ustekinumab)

Unknown status
  • Alzheimer Disease
  • Westport, Connecticut
    Millennium Magnetic Technologies, LLC
Sep 10, 2016

Primary Open Angle Glaucoma, Ocular Hypertension, Elevated Intraocular Pressure Trial in Morrow (ALZ-1101, Latanoprost)

Completed
  • Primary Open Angle Glaucoma
  • +2 more
  • Morrow, Georgia
    (unnamed)
Sep 29, 2014